Abstract
New therapies have been introduced for the prophylaxis and treatment of respiratory syncytial virus (RSV) infection in recent years. The aim of the study was to determine the epidemiological and clinical characteristics of infants hospitalized with bronchiolitis in our area. All patients under 1 year of age admitted with acute bronchiolitis during four consecutive RSV seasons from February 1, 1997 to June 30, 2000 were enrolled in the study. The records of patients admitted during the first season were reviewed retrospectively while the rest were followed prospectively. A total of 636 infants with bronchiolitis were admitted and RSV infection was documented in 61% of those tested. Admission to intensive care unit (ICU) was required for 6.2% of them and was more common in premature infants (26%) (p < 0.001). Case fatality rate was 0.7% (overall 0.3%). RSV bronchiolitis accounted for about 12% of all infant admissions during the 5 months of the yearly outbreak. Patients with documented RSV infection had a more severe illness with a higher ICU admission rate (6 vs. 1%, p = 0.008) and longer duration of hospitalization (mean 6.3 vs. 5.3 days, p < 0.001) compared to those who tested negative. Although none of the patients had a positive blood culture on admission a considerable number of them (210/636, 33%) were treated with antibiotics. RSV infection has a significant impact on infant morbidity in our settings which is more serious among those born prematurely. Documentation of RSV infection may be a marker of more severe illness in infants hospitalized with bronchiolitis. Antibiotic use has to be restricted since the occurrence of a serious bacteraemic illness on admission is a very rare event.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD (eds), Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia: WB Saunders, 1997; 2084–2111.
American Academy of Pediatrics, Committee on Infectious Diseases. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus. Pediatrics 1996; 97: 137–140.
American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IVIG Pediatrics 1998; 102: 1211–1215.
Kattan M. Epidemiologic evidence of increased airway reactivity in children with a history of bronchiolitis. J Pediatr 1999; 135: S8–S13.
Lina B, Valette M, Foray S, et al. Surveillance of community acquired viral infections due to respiratory viruses in Rhone Alpes (France) during winter 1994 to 1995. J Clin Mcrobiol 1996; 34: 3007–3011.
Mlinaric-Galinovic G, Ugrcic I, Bozicov J. Respiratory syncytial virus infections in SR Croatia, Yugoslavia. Pediatr Pulmonol 1987; 3: 304–308.
Dagan R, Landau D, Haikin H, Tal A. Hospitalization of Jewish and Bedouin infants in Southern Israel for bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J 1993; 12: 381–386.
Tellez A, Perez-Brena P, Fernandez-Patino MV, Leon P, Anda P, Najera R. Acute respiratory disease in Spain: Seven years of experience. Rev Infect Dis 1990; 12: 745–753.
Clarke SKR, Gardner PS, Poole PM, Simpson H, O'H Tobin J. Respiratory syncytial virus infection: Admissions to hospital in industrial, urban and rural areas. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines. Br Med J 1978; 2: 796–798.
Weigl JAI, Puppe W, Grondhal B, Schmitt HJ. Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2000; 19: 336–343.
Popow-Kraupp T, Kunz C, Huber E. Respiratory virus infection in hospitalized children in Austria 1979-1982. Diagnosis by immunofluorescence. Infection 1984; 12: 185–189.
Kim HW, Arrobio JO, Brandt CD, et al. Epidemiology of Respiratory Syncytial Virus Infection in Washington DC. Importance of the virus in different respiratory disease syndromes and temporal distribution of infection. Am J Epidemiol 1973; 98: 216–255.
Mufson MA, Levine HD, Wasil RE, et al. Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol 1973; 98: 88–95.
Kristensen K, Dahm T, Frederiksen PS, et al. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis 1998; 11: 996–1000.
Brandenburg AH, Jeannet PY, Steensen-Moll HA, et al. Local variabiltiy in respiratory syncytial virus disease severity. Arch Dis Child 1997; 77: 410–414.
Behrendt CE, Decker MD, Burch DJ, Watson PH for the International study group. International variation in the management of infants hospitalized with respiratory virus infection. Eur J Pediatr 1998; 157: 215–220.
Gardner PS. How etiologic, pathologic and clinical diagnoses can be made in a correlated fashion. Pediatr Res 1977; 11: 254–261.
Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: A randomized controlled trial. Lancet 1996; 348: 292–295.
Avendano LF, Larranaga C, Palomino M, et al. Community-and hospital-acquired respiratory syncytial virus infections in Chile. Pediatr Infect Dis J 1991; 10: 564–568.
Weber MW, Dackour R, Usen S, et al. The clinical spectrum of respiratory syncytial virus disease in The Gambia. Pediatr Infect Dis J 1998; 17: 224–230.
Johnson A-WBR, Aderele WI, Osinusi K, et al. Acute bronchiolitis in tropical Africa: A hospital-based perspective in Ibadan, Nigeria. Pediatr Pulmonol 1996; 22: 236–247.
Bedoya VI, Abad V, Trujillo H. Frequency of respiratory syncytial virus in hospitalized infants with lower acute respiratory tract infection in Colombia. Pediatr Infect Dis J 1996; 15: 1223–1224.
Hall CB. Respiratory syncytial virus: A continuing culprit and conundrum. J Pediatr 1999; 135: S2–S7.
van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719–724.
Takimoto S, Grandien M, Ishida MA, et al. Comparison of enzyme linked immunosorbent assay, indirect immunofluorescence assay and virus isolation for detection of respiratory viruses in nasopharyngeal secretions. J Clin Microbiol 1991; 29: 470–474.
Dominguez EA, Taber LH, Couch RB. Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children. J Clin Microbiol 1993; 31: 2286–2290.
Avila M, Salomon H, Carballal G, et al. Isolation and identification of viral agents in Argentinian children with acute lower respiratory tract infection. J Infect Dis 1990; 12: S974–S981.
Adcock PM, Stout GC, Hauck MA, Marshall GS. Effect of rapid viral diagnosis on the management of children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J 1997; 16: 842–846.
Englund J, Piedra PA, Jewell A, et al. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J Clin Microbiol 1996; 34: 1649–1653.
Simoes EAF. Respiratory syncytial virus infection. The Lancet 1999; 354: 847–852.
Navas L, Wang E, de Carvalho V, Robinson J and the Pediatric Investigators Collaborative Network in Canada. Improved outcome of respiratory syncytial virus infection in a high risk hospitalized population of Canadian children. J Pediatr 1992; 121: 348–354.
Hall CB, Powell KR, Schnabel KC, et al. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988; 113: 266–271.
Samson L, Cooke C, Mac Donald NE for PICNIC. Analysis of antibiotic use and misuse in children hospitalized with RSV infection (abstract). Pediatr Res 1996; 39: 111A.
Andrade MA, Hoberman A, Glustein J, et al. Acute otitis media in children with bronchiolitis. Pediatrics 1998; 101: 617–619.
Dowell SF, Marcy SM, Phillips WR, et al. Otitis media-Principles of judicious use of antimicrobial agents. Pediatrics 1998; 101: S165–S184.
Baraff LJ, Bass JW, Fleisher GR, et al. Practice guidelines for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993; 92: 1–12.
Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543–546.
Langley JM, Wang EEL, Law BJ, et al. Economic evaluation of respiratory syncytial virus infection in Canadian children: Paediatric Investigators Collaborative Network of Infections in Canada (PICNIC) study. J Pediatr 1997; 131: 113–117.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsolia, M., Kafetzis, D., Danelatou, K. et al. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol 18, 55–61 (2003). https://doi.org/10.1023/A:1022556215190
Issue Date:
DOI: https://doi.org/10.1023/A:1022556215190